We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+12.53%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$21.3B
AUM Growth
+$4.08B
Cap. Flow
+$2.12B
Cap. Flow %
9.98%
Top 10 Hldgs %
58.73%
Holding
1,162
New
154
Increased
426
Reduced
439
Closed
125

Sector Composition

Rank Sector Weight
1 Energy 68.07%
2 Materials 6.1%
3 Technology 3.07%
4 Financials 2.69%
5 Utilities 2.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMTX icon
576
Immatics
IMTX
$1.24B
$1.07M 0.01%
109,138
-944
-0.9% -$9.25K
AAOI icon
577
Applied Optoelectronics
AAOI
$8.04B
$1.07M 0.01%
+12,672
New +$809K
BKR icon
578
Baker Hughes
BKR
$56.8B
$1.07M 0.01%
17,527
+832
+5% +$48.1K
BCAX
579
Bicara Therapeutics
BCAX
$1.78B
$1.03M ﹤0.01%
51,580
+6,602
+15% +$114K
MGEE icon
580
MGE Energy Inc
MGEE
$3.11B
$1.02M ﹤0.01%
13,241
-646
-5% -$50.9K
SEDG icon
581
SolarEdge
SEDG
$2.59B
$1.02M ﹤0.01%
20,008
-6,488
-24% -$244K
RSG icon
582
Republic Services
RSG
$66.7B
$1.02M ﹤0.01%
4,658
-321
-6% -$70.4K
VRTX icon
583
Vertex Pharmaceuticals
VRTX
$121B
$1.01M ﹤0.01%
2,268
-230
-9% -$107K
FULT icon
584
Fulton Financial
FULT
$4.7B
$1.01M ﹤0.01%
49,692
-1,174
-2% -$24.2K
VEEV icon
585
Veeva Systems
VEEV
$30.3B
$999K ﹤0.01%
5,687
-1,015
-15% -$199K
CRVS icon
586
Corvus Pharmaceuticals
CRVS
$1.1B
$998K ﹤0.01%
68,194
+6,876
+11% +$110K
TSHA icon
587
Taysha Gene Therapies
TSHA
$1.59B
$997K ﹤0.01%
222,986
-1,934
-0.9% -$8.99K
UHT
588
Universal Health Realty Income Trust
UHT
$608M
$988K ﹤0.01%
24,407
-1,988
-8% -$82.4K
GEVO icon
589
Gevo
GEVO
$397M
$976K ﹤0.01%
357,376
+25,217
+8% +$52.2K
SNPS icon
590
Synopsys
SNPS
$71.5B
$967K ﹤0.01%
2,439
-1,189
-33% -$538K
OLMA icon
591
Olema Pharmaceuticals
OLMA
$1.02B
$955K ﹤0.01%
64,035
-557
-0.9% -$12.4K
CSGP icon
592
CoStar Group
CSGP
$11.3B
$954K ﹤0.01%
23,646
+691
+3% +$36K
MDLZ icon
593
Mondelez International
MDLZ
$77.7B
$953K ﹤0.01%
16,541
-1,209
-7% -$70K
EQIX icon
594
Equinix
EQIX
$107B
$934K ﹤0.01%
953
-463
-33% -$412K
BLDP
595
Ballard Power Systems
BLDP
$874M
$929K ﹤0.01%
383,981
+26,279
+7% +$62.7K
BSX icon
596
Boston Scientific
BSX
$65.8B
$923K ﹤0.01%
14,707
-2,593
-15% -$207K
RIGL icon
597
Rigel Pharmaceuticals
RIGL
$680M
$923K ﹤0.01%
34,120
+7,106
+26% +$239K
DLX icon
598
Deluxe
DLX
$1.19B
$922K ﹤0.01%
33,491
-3,490
-9% -$91.3K
CRGY icon
599
Crescent Energy
CRGY
$3.72B
$919K ﹤0.01%
68,064
-7,090
-9% -$74.3K
RDY icon
600
Dr. Reddy's Laboratories
RDY
$9.82B
$884K ﹤0.01%
63,836
+800
+1% +$11.1K

Similar funds

ALPS Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, ALPS Advisors held 1,162 positions worth $21.3B, up 24% from $17.2B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

ALPS Advisors deployed $2.12B of net new capital in Q1 2026, opening 154 new positions and adding to 426 existing holdings. Its largest new stake was Eaton Vance Total Return Bond ETF: 1,017,240 shares worth $51.6M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 63% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was Uranium Energy, an estimated $123M trimmed.

  • ALPS Advisors's largest Q1 2026 buy was Eaton Vance Total Return Bond ETF: 1,017,240 shares worth $51.6M.
  • ALPS Advisors added most to MPLX in Q1 2026, an estimated $1.51B increase.
  • ALPS Advisors's biggest Q1 2026 reduction was Uranium Energy, cutting an estimated $123M.
  • ALPS Advisors fully exited Columbia EM Core ex-China ETF in Q1 2026, selling an estimated $15.5M.
  • ALPS Advisors's ten largest holdings make up 59% of its $21.3B portfolio in Q1 2026.
  • ALPS Advisors opened 154 new positions and closed 125 in Q1 2026.
  • ALPS Advisors's portfolio value rose 24% quarter-over-quarter to $21.3B.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.